Richard Peter Norman : Citation Profile


Are you Richard Peter Norman?

University of Technology Sydney

4

H index

2

i10 index

78

Citations

RESEARCH PRODUCTION:

7

Articles

10

Papers

RESEARCH ACTIVITY:

   6 years (2007 - 2013). See details.
   Cites by year: 13
   Journals where Richard Peter Norman has often published
   Relations with other researchers
   Recent citing documents: 5.    Total self citations: 5 (6.02 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pno96
   Updated: 2024-11-08    RAS profile: 2023-07-04    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Richard Peter Norman.

Is cited by:

Viney, Rosalie (9)

Lancsar, Emily (5)

Hole, Arne (4)

Vass, Caroline (3)

Devlin, Nancy (3)

Lorgelly, Paula (3)

Brazier, John (3)

Gu, Yuanyuan (3)

van Exel, Job (2)

Byrnes, Joshua (2)

Hollingsworth, Bruce (2)

Cites to:

Lancsar, Emily (8)

Viney, Rosalie (7)

Savage, Elizabeth (5)

Brazier, John (5)

Johannesson, Magnus (4)

Fiebig, Denzil (4)

Tsuchiya, Aki (4)

Bleichrodt, Han (4)

Hall, Jane (3)

Wakker, Peter (3)

Wasi, Nada (3)

Main data


Where Richard Peter Norman has published?


Journals with more than one article published# docs
Applied Health Economics and Health Policy3
Health Policy2

Working Papers Series with more than one paper published# docs
Working Papers / CHERE, University of Technology, Sydney10

Recent works citing Richard Peter Norman (2024 and 2023)


YearTitle of citing document
2024Making recommendations to subsidize new health technologies in Australia: A qualitative study of decision-makers’ perspectives on committee processes. (2024). Lancsar, Emily ; Carter, Stacy M ; Sellars, Marcus ; Coast, Joanna ; Howard, Kirsten. In: Health Policy. RePEc:eee:hepoli:v:139:y:2024:i:c:s0168851023002488.

Full description at Econpapers || Download paper

2023Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand. (2023). Blizzard, Leigh C ; Palmer, Andrew J ; Carroll, William M ; Butzkueven, Helmut ; Simpson-Yap, Steve ; Kalincik, Tomas ; Mason, Deborah F ; Norman, Richard ; Taylor, Bruce V ; Campbell, Julie A ; Henson, Glen J ; Claflin, Suzi ; van der Mei, Ingrid. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:6:d:10.1007_s10198-022-01518-x.

Full description at Econpapers || Download 2023

Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients. (2023). Wang, Pei ; Luo, Nan ; Zhao, Chun-Hua ; Zhu, Yan-Bo ; He, Jun-Yi ; Pan, Chen-Wei. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:6:d:10.1007_s10198-022-01523-0.

Full description at Econpapers || Download paper

2023U.K. utility weights for the EORTC QLU‐C10D. (2019). Viney, Rosalie ; Street, Deborah J ; Pickard, Simon A ; Cella, David ; Brazier, John E ; Rowen, Donna ; Consortium, The Mauca ; Merciecabebber, Rebecca ; Of, Treatment ; Norman, Richard ; King, Madeleine T ; Revicki, Dennis. In: Health Economics. RePEc:wly:hlthec:v:28:y:2019:i:12:p:1385-1401.

Full description at Econpapers || Download paper

2024Addressing the distributional consequences of spillovers in health economic evaluation: A prioritarian approach. (2024). Cullinan, John ; Henry, Edward. In: Health Economics. RePEc:wly:hlthec:v:33:y:2024:i:4:p:764-778.

Full description at Econpapers || Download paper

Works by Richard Peter Norman:


YearTitleTypeCited
2011Introduction and uptake of new medical technologies in the Australian health care system: A qualitative study In: Health Policy.
[Full Text][Citation analysis]
article3
2009International perspectives on the cost-effectiveness of tandem mass spectrometry for rare metabolic conditions In: Health Policy.
[Full Text][Citation analysis]
article2
2007Economic Evaluation of Positron Emission Tomography (PET) in Non Small Cell Lung Cancer (NSCLC), CHERE Working Paper 2007/6 In: Working Papers.
[Full Text][Citation analysis]
paper0
2007Valuing EQ-5D health states: A review and analysis, CHERE Working Paper 2007/9 In: Working Papers.
[Full Text][Citation analysis]
paper7
2008A model for best practice HTA In: Working Papers.
[Full Text][Citation analysis]
paper0
2008The effect of discounting on quality of life valuation using the Time Trade-Off, CHERE Working Paper 2008/3 In: Working Papers.
[Full Text][Citation analysis]
paper0
2008Dementia Care Mapping and Patient-Centred Care in Australian residential homes: An economic evaluation of the CARE Study, CHERE Working Paper 2008/4 In: Working Papers.
[Full Text][Citation analysis]
paper0
2008Equity weights for economic evaluation: An Australian Discrete Choice Experiment, CHERE Working Paper 2008/5 In: Working Papers.
[Full Text][Citation analysis]
paper1
2009Issues in evaluating the costs and cost-effectiveness of Cognitive Behavioural Therapy for overweight/obese adolescents, CHERE Working Paper 2009/1 In: Working Papers.
[Full Text][Citation analysis]
paper0
2011Understanding the costs of care for cystic fibrosis: an analysis by age and severity. CHERE Working Paper 2011/1 In: Working Papers.
[Full Text][Citation analysis]
paper4
2012Deriving utility weights for the EQ-5D-5L using a discrete choice experiment. CHERE Working Paper 2012/01 In: Working Papers.
[Full Text][Citation analysis]
paper0
2012Measuring the loss of consumer choice in mandatory health programs using Discrete Choice Experiments. CHERE Working Paper 2012/04 In: Working Papers.
[Citation analysis]
paper0
2013Measuring the Loss of Consumer Choice in Mandatory Health Programmes Using Discrete Choice Experiments In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article2
2013A Pilot Discrete Choice Experiment to Explore Preferences for EQ-5D-5L Health States In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article36
2013A Comparison of the EQ-5D-3L and ICECAP-O in an Older Post-Acute Patient Population Relative to the General Population In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article5
2007The cost-utility of magnetic resonance imaging for breast cancer in BRCA1 mutation carriers aged 30–49 In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2013EFFICIENCY AND EQUITY: A STATED PREFERENCE APPROACH In: Health Economics.
[Full Text][Citation analysis]
article18

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated November, 3 2024. Contact: CitEc Team